Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have identified a small molecule that can inhibit a cancer ...
LRK-4189, which targets PIP4K2C, a key cancer cell fitness target, is being developed for microsatellite stable (MSS) ...
When a cell receives a message from outside, it generates a molecule called cyclic AMP (cAMP) to relay this message. To ...
Molecular glues are revolutionizing cancer therapy by targeting undruggable proteins for degradation, enhancing precision ...
This research led to Balu-Iyer founding the Buffalo-based company Immune Modulatory Therapies LLC in 2019. His UB co-founders ...
Two scientists at the Johns Hopkins School of Medicine have been selected for membership in the National Academy of Inventors ...
MedPage Today on MSN
The Latest on Emerging Therapies for Metastatic HR+/HER2- Breast Cancer
Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...
Stanford Medicine investigators have unearthed the biological process by which mRNA-based vaccines for COVID-19 can cause ...
The middle class does not need to be pacified. It needs to be trusted. At the moment, its 'mood' is being managed without ...
A Nobel laureate, he identified an enzyme that cuts DNA, laying the groundwork for milestones in scientific research and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback